Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.69% |
| 2 | Financials | 6.83% |
| 3 | Healthcare | 6.42% |
| 4 | Industrials | 4.98% |
| 5 | Consumer Discretionary | 4.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
CALL
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.93B
| $71M | 0.04% |
752,900
-441,000
| -37% | -$37.5M |
|
452
Moderna
MRNA
$57.9B
| $70.9M | 0.04% |
184,328
-234,577
| -56% | -$86.5M |
|
|
LSI
453
DELISTED
Life Storage, Inc.
LSI
| $70.9M | 0.04% |
618,257
+74,654
| +14% | +$8.88M |
|
454
Cognizant
CTSH
$27.9B
| $70.4M | 0.04% |
948,694
-689,959
| -42% | -$50.9M |
|
455
MongoDB
MDB
$34.7B
| $70.4M | 0.04% |
149,307
-51,406
| -26% | -$20.7M |
|
456
CALL
AbbVie
ABBV
$468B
| $70M | 0.04% |
649,300
-4,900
| -0.7% | -$560K |
|
457
Chipotle Mexican Grill
CMG
$46.7B
| $70M | 0.04% |
1,926,100
+618,250
| +47% | +$22.5M |
|
458
PepsiCo
PEP
$196B
| $70M | 0.04% |
465,325
-541,980
| -54% | -$83.9M |
|
459
PUT
First Solar
FSLR
$23B
| $69.9M | 0.04% |
732,500
+345,000
| +89% | +$32M |
|
460
Curtiss-Wright
CW
$23.5B
| $69.8M | 0.04% |
553,214
-213,129
| -28% | -$25.5M |
|
461
Chubb
CB
$132B
| $69.8M | 0.04% |
402,228
-107,521
| -21% | -$18.8M |
|
462
Ovintiv
OVV
$18.5B
| $69.7M | 0.04% |
2,120,772
+1,228,297
| +138% | +$33.9M |
|
463
CALL
Boeing
BA
$169B
| $69.6M | 0.04% |
316,600
+212,500
| +204% | +$47.4M |
|
464
Agilent Technologies
A
$44.9B
| $69.4M | 0.04% |
440,837
+325,284
| +282% | +$52.6M |
|
|
HZNP
465
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $69.4M | 0.04% |
633,752
+59,741
| +10% | +$6.2M |
|
466
Skyworks Solutions
SWKS
$10.1B
| $69.4M | 0.04% |
421,028
+221,316
| +111% | +$40.5M |
|
467
Coca-Cola Europacific Partners
CCEP
$47.7B
| $69.3M | 0.04% |
1,253,586
+907,905
| +263% | +$54M |
|
|
468
AbbVie
ABBV
$468B
| $69.2M | 0.04% |
641,156
-361,369
| -36% | -$41.3M |
|
469
PUT
Royal Bank of Canada
RY
$285B
| $69M | 0.04% |
+600,000
| New | +$61.1M |
|
470
Paycom
PAYC
$10.3B
| $69M | 0.04% |
139,117
-116,197
| -46% | -$51.8M |
|
|
MRSH
471
Marsh
MRSH
$91.6B
| $68.9M | 0.04% |
454,998
+395,678
| +667% | +$59.8M |
|
472
PUT
Dow Inc
DOW
$23.4B
| $68.8M | 0.04% |
1,195,500
+376,400
| +46% | +$23M |
|
473
Allstate
ALL
$64.2B
| $68.8M | 0.04% |
540,399
-183,830
| -25% | -$24.3M |
|
474
Waste Management
WM
$89.6B
| $68.8M | 0.04% |
460,303
+43,902
| +11% | +$6.57M |
|
475
The Mosaic Company
MOS
$7.76B
| $68.5M | 0.04% |
1,918,747
+1,068,720
| +126% | +$34.2M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander deployed $8.65B of net new capital in Q3 2021, opening 1,245 new positions and adding to 2,719 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.